+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molecular Diagnostics Market Global Report 2020-30

  • ID: 5014052
  • Report
  • April 2020
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Abbott
  • BD
  • Bio-Rad Laboratories
  • Diasorin
  • Hologic Inc.
  • Other players
Molecular Diagnostics Market Global Report 2020-30 from the author provides the strategists, marketers and senior management with the critical information they need to assess the global molecular diagnostics market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:

Where is the largest and fastest growing market for the molecular diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Molecular Diagnostics market global report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider molecular diagnostics market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The molecular diagnostics market section of the report gives context. It compares the molecular diagnostics market with other segments of the molecular diagnostics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, molecular diagnostics indicators comparison.
Scope

Markets Covered: 1) By Technology: Polymerase Chain Rreaction (PCR); DNA Sequencing; Next-Generation Sequencing; 2) By Product: Instruments; Reagents and Consumables; Software & Services; 3) By Application: Oncology; Pharmacogenomics; Infectious Diseases; Genetic Testing; Neurological Disease; Cardiovascular Disease; Microbiology; Others; 4)By End-User: Hospitals; Laboratories; Others (Blood Banks, Home Health Agencies, and Nursing Homes)

Companies Mentioned: Becton; BioMérieux SA.; Danaher Corporation; Grifols; Hologic Inc.

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • BD
  • Bio-Rad Laboratories
  • Diasorin
  • Hologic Inc.
  • Other players
1. Executive Summary

2. Molecular Diagnostics Market Characteristics

3. Molecular Diagnostics Market Size And Growth
3.1. Global Molecular Diagnostics Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Molecular Diagnostics Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Molecular Diagnostics Market Segmentation
4.1. Global Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Polymerase Chain Rreaction (PCR)
DNA Sequencing
Next-Generation Sequencing
4.2. Global Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Instruments
  • Reagents and Consumables
  • Software & Services
4.3. Global Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oncology
  • Pharmacogenomics
  • Infectious Diseases
  • Genetic Testing
  • Neurological Disease
  • Cardiovascular Disease
  • Microbiology
  • Others
4.4. Global Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospitals
  • Laboratories
  • Others (Blood Banks, Home Health Agencies, and Nursing Homes)
5. Molecular Diagnostics Market Regional And Country Analysis
5.1. Global Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Molecular Diagnostics Market
6.1. Asia-Pacific Molecular Diagnostics Market Overview
6.2. Asia-Pacific Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Molecular Diagnostics Market
7.1. China Molecular Diagnostics Market Overview
7.2. China Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Molecular Diagnostics Market
8.1. India Molecular Diagnostics Market Overview
8.2. India Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Molecular Diagnostics Market
9.1. Japan Molecular Diagnostics Market Overview
9.2. Japan Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Molecular Diagnostics Market
10.1. Australia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Molecular Diagnostics Market
11.1. Indonesia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Molecular Diagnostics Market
12.1. South Korea Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Molecular Diagnostics Market
13.1. Western Europe Molecular Diagnostics Market Overview
13.2. Western Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Molecular Diagnostics Market
14.1. UK Molecular Diagnostics Market Overview
14.2. UK Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Molecular Diagnostics Market
15.1. Germany Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Molecular Diagnostics Market
16.3. France Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Molecular Diagnostics Market
17.1. Eastern Europe Molecular Diagnostics Market Overview
17.2. Eastern Europe Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Molecular Diagnostics Market
18.1. Russia Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Molecular Diagnostics Market
19.1. North America Molecular Diagnostics Market Overview
19.2. North America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Molecular Diagnostics Market
20.1. USA Molecular Diagnostics Market Overview
20.2. USA Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Molecular Diagnostics Market
21.1. South America Molecular Diagnostics Market Overview
21.2. South America Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Molecular Diagnostics Market
22.1. Brazil Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Molecular Diagnostics Market
23.1. Middle East Molecular Diagnostics Market Overview
23.2. Middle East Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Molecular Diagnostics Market
24.1. Africa Molecular Diagnostics Market Overview
24.2. Africa Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Molecular Diagnostics Market Competitive Landscape And Company Profiles
25.1. Molecular Diagnostics Market Competitive Landscape
25.2. Molecular Diagnostics Market Company Profiles
25.2.1. Becton
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. BioMérieux SA.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Danaher Corporation
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Grifols
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Hologic Inc.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Molecular Diagnostics Market

27. Molecular Diagnostics Market Trends And Strategies

28. Molecular Diagnostics Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • BD
  • Bio-Rad Laboratories
  • Diasorin
  • Hologic Inc.
  • Other players
The molecular diagnostics market consists of sales of molecular diagnostics services and related products. Molecular diagnostics is a term used to describe a class of techniques that are used to examine biological markers in the genetic code (genome) of an organism and to determine how their cells express their genes as proteins.

The global molecular diagnostics market was worth $8.62 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 8.82% and reach $12.09 billion by 2023.

The molecular diagnostics market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019.

The molecular diagnostics market covered in this report is segmented by technology into polymerase chain rreaction (PCR); DNA sequencing; next-generation sequencing. It is also segmented by product into instruments; reagents and consumables; software & services, by application into oncology; pharmacogenomics; infectious diseases; genetic testing; neurological disease; cardiovascular disease; microbiology; others and by end-user into hospitals; laboratories; others (blood banks, home health agencies, and nursing homes)

The global prevalence of infectious diseases and cancers of different forms drives the molecular diagnostics market. The increasing prevalence of infectious diseases and various types of cancer creates a demand for new diagnostic procedures including fast and specific molecular diagnostic tests. According to the International Agency for Research on Cancer (IARC), in 2018, there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide, and by 2040, the number is expected to increase to 27.5 million new cancer cases and 16.3 million cancer. The increasing prevalence of cancer globally increases the demand for molecular diagnostic tests for effective diagnosis of cancer over the coming years, thereby contributing to the growth of the market.

The complex regulatory frameworks delaying the approval of new molecular diagnostics tests is a key factor hampering the growth of the molecular diagnostics market. The requirements of the FDA for the tests are changing and thereby increasing the time required to obtain pre-market approval. For instance, in 2013, the FDA has tried to establish a new regulatory system for LDTs (laboratory-developed tests) that are officially governed under the Clinical Laboratory Improvement Amendments (CLIA) and does not come under the purview of the FDA. However in 2017 senior officials circulated a draft proposal known as the Diagnostic Accuracy and Innovation Act (DAIA) to serve as the basis for the creation of a new regulatory system for LDTs. The complexity involved in regulatory and legal requirements that applies to molecular diagnostics tests is expected to limit the growth of the molecular diagnostics market.

The advances in genomics and proteomics is a key trend driving the growth of the molecular diagnostics market. Polymerase chain reaction (PCR) is a recent development in genomics and helps in discovering new approaches to molecular diagnosis for disease diagnosis and pathogenesis of diseases. This enables better monitoring and a fast diagnosis and major organizations are investing to have a competitive edge. Following the trend, Genome Canada, a source of funding for genomics and proteomics, announced plans to invest $16 million between the period April 2015 and March 2017. The growing research in proteomics and genomics will help develop more advanced molecular diagnostic techniques in the forecast period.

In August 2018, Bruker Corporation, an American based manufacturer of scientific instruments for molecular and materials research announced plans to acquire majority stake in Hain Lifescience GmbH for undisclosed amount. This acquisition will help Bruker to expand its presence in attractive microbiology and virology infectious disease MDx markets, and add tuberculosis and mycobacteria testing, virology and in human genetics MDx, and a pipeline for multiplex syndromic panel testing to it's portfolio. Hain Lifescience GmbH is an infectious disease molecular diagnostics (MDx) specialist and provides solutions for detecting microbial and viral pathogens, antibiotic resistance testing, and human genetic diseases.

Major players in the market are Becton, BioMérieux SA., Danaher Corporation, Grifols, Hologic Inc., Novartis AG, QIAGEN, Siemens Healthcare GmbH, Abbott and Dickinson and Company.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Becton
  • BioMérieux SA.
  • Danaher Corporation
  • Grifols
  • Hologic Inc.
  • Novartis AG
  • QIAGEN
  • Siemens Healthcare GmbH
  • Abbott
  • Dickinson and Company
  • Hoffmann-La Roche Ltd.
  • BD
  • Bio-Rad Laboratories
  • Johnson & Johnson
  • Cepheid
  • Roche Diagnostics
  • Alere
  • Bayer AG
  • Dako
  • Sysmex Corporation
  • Agilent Technologies
  • Diasorin
  • Illumina
  • Thermo Fisher Scientific
  • Biocartis Group NV
  • Other players
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll